26
|
Zauderer M, Muller S, Lai W, Ni A, Jungbluth A, Ginsberg M, Daly R, Hellmann M, Ladanyi M, Sauter J. P2.06-40 VISTA is Highly Expressed in Malignant Pleural Mesothelioma (MPM) and Independent of PD-L1 Expression. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Zheng Y, Xu QF, Chen HY, Ye CX, Lai W, Maibach HI. Inhibition of MMPs Cat G and downregulates the signaling of TGF-β/Smad in chronic photodamaged human fibroblasts. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2018; 21:5160-5165. [PMID: 29228428 DOI: 10.26355/eurrev_201711_13833] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To understand the action of Cathepsin G (Cat G) and matrix metalloproteases (MMPs) on the β/Smad pathway of transforming growth factor β (TGF-β) in chronically photodamaged human fibroblasts. Cat G plays a significant role in the process of skin photoaging and in collagen synthesis and degradation which is induced by UV irradiation it could interact with TGF-β/Smad signaling. No available studies have thoroughly explored its molecular mechanisms of photoaging regulation. PATIENTS AND METHODS Fibroblasts were divided into 4 groups: (1) control, (2) UVA irradiation of 25 J/cm2, (3) UVA irradiation of 25 J/cm2 + MMPs inhibitor, and (4) 25 J/cm2 UVA irradiation + Cat G inhibitor. All treatments were repeated daily for 21 days. Western blot and ELISA was employed to detect Protein levels for Cat G, MMPs, and several smads. RESULTS Compared to UVA-irradiated cells, the addition of MMPs inhibitor downregulated the expression of smad2, smad3, and smad4 as well as TGF-β. The addition of Cat G inhibitor downregulated the expression of smad2, smad3, and smad4 as well as TGF-β. These data suggest that TGF-β/Smad signaling was decreased by inhibition of MMPs and Cat G decreased in chronically human fibroblasts which are photo-damaged. CONCLUSIONS These results may help expand our knowledge of mechanisms mediating photoaging and is possibly instrumental to the exploration of novel anti-photoaging treatments.
Collapse
|
28
|
Chiu T, Yu H, Lai W, Li H, Tsai E, Chen Y. MOVING FROM FRAGMENTED TOWARD AN INTEGRATED SYSTEM: A NEW LONG-TERM CARE POLICY IN FAST-AGING COUNTRY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Zheng YH, Xiong B, Deng YY, Lai W, Zheng SY, Bian HN, Liu ZA, Huang ZF, Sun CW, Li HH, Luo HM, Ma LH, Chen HX. [Effects of allogeneic bone marrow mesenchymal stem cells on polarization of peritoneal macrophages in rats with sepsis]. ZHONGHUA SHAO SHANG ZA ZHI = ZHONGHUA SHAOSHANG ZAZHI = CHINESE JOURNAL OF BURNS 2017; 33:217-223. [PMID: 28427135 DOI: 10.3760/cma.j.issn.1009-2587.2017.04.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the effects of allogeneic bone marrow mesenchymal stem cells (BMSCs) on polarization of peritoneal macrophages isolated from rats with sepsis induced by endotoxin/lipopolysaccharide (LPS). Methods: (1) BMSCs were isolated, cultured and purified from 5 SD rats with whole bone marrow adherent method. The third passage of cells were collected for morphologic observation, detection of expressions of stem cell surface markers CD29, CD44, CD45, and CD90 with flow cytometer, and identification of osteogenic and adipogenic differentiation. (2) Another 45 SD rats were divided into sham injury group (SI, n=5), LPS control group (LC, n=20), and BMSCs-treated group (BT, n=20) according to the random number table. Rats in groups LC and BT were injected with LPS (5 mg/kg) via tail vein to induce sepsis; rats in group SI were injected with the same amount of normal saline to simulate the damage. At post injury hour (PIH) 1, rats in group BT were given 1 mL BMSCs (2×10(6)/mL) via tail vein injection; rats in another two groups were injected with equal volume of phosphate buffer saline. Five rats in group SI at PIH 24 and in groups LC and BT at PIH 6, 12, 24, and 48 were sacrificed to harvest lung tissue for pathological observation with HE staining. In addition, rats in group SI at PIH 24 and in groups LC and BT at PIH 24 and 48 were simultaneously performed with intraperitoneal injection of low-glucose DMEM. Then peritoneal fluid was harvested to culture peritoneal macrophages. Flow cytometer was used to assess the positive expression of cell makers of macrophages including CD68 (making gate), CD11c, and CD206 in group SI at PIH 24 and in groups LC and BT at PIH 24 and 48. Data were processed with one-way analysis of variance and LSD test. Results: (1) The third passage of cells showed uniform fiber-like shape similar to fibroblasts. These cells showed positive expressions of CD29, CD44, CD90 and weak positive expression of CD45. They were able to differentiate into osteoblasts and adipocytes. These cells were identified as BMSCs. (2) At PIH 24, the structure of pulmonary alveoli of rats in group SI was clear and complete with no congestion or inflammatory cell infiltration. At PIH 6, the structure of pulmonary alveoli of rats in groups LC and BT was clear with a small amount of inflammatory cell infiltration, slight congestion and pulmonary interstitial thickening. At PIH 12, the inflammatory responses in lung tissue of rats in group LC were more severe than those in group BT with a large amount of inflammatory cell infiltration, serious congestion, and obvious pulmonary interstitial thickening. The pathological results of rats in group BT at PIH 12 was consistent with the results at PIH 6. At PIH 24, the pathological results of rats in groups LC and BT were similar to the results at PIH 12. At PIH 48, the structure of pulmonary alveoli tissue of rats in group LC was still severely disrupted, with a large number of inflammatory cell infiltration and congestion in lung tissue, but pulmonary interstitial thickening was slightly alleviated than before. The condition of rats in group BT nearly recovered to that in group SI. (3) At PIH 24, the positive expression rate of CD11c in peritoneal macrophages of rats in group LC [(83±10)%] was close to that in group BT [(87±7)%, P>0.05], and they were both significantly higher than the rate in group SI [(55±12)%, with P values below 0.01]. The positive expression rate of CD11c in peritoneal macrophages of rats in group LC [(59±11)%] at PIH 48 was close to that in group SI at PIH 24 (P>0.05), and they were both significantly higher than the rate in group BT [(20±11)%] at PIH 48 (with P values below 0.01). At PIH 24, the positive expression percentages of CD206 in peritoneal macrophages of rats were similar among the three groups (with P values above 0.05). The positive expression percentage of CD206 in peritoneal macrophages of rats in group SI at PIH 24 was close to that in group BT at PIH 48 (P>0.05), and they were both significantly lower than the percentage in group LC at PIH 48 (with P values below 0.01). Conclusions: BMSCs can reduce the pathological inflammatory responses in the lung of rats with sepsis and inhibit peritoneal macrophages from polarizing into M1 phenotype, whereas they can not promote macrophages to polarize into M2 phenotype.
Collapse
|
30
|
Long H, Gao M, Zhu Y, Liu H, Zhou Y, Liao L, Lai W. The effects of menstrual phase on orthodontic pain following initial archwire engagement. Oral Dis 2017; 23:331-336. [PMID: 27873444 DOI: 10.1111/odi.12612] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2016] [Revised: 10/25/2016] [Accepted: 11/02/2016] [Indexed: 02/05/2023]
|
31
|
Shan D, Long H, Lai W. TRPA1 may contribute to the exacerbation of oral lichen planus through Koebner phenomenon. Oral Dis 2017; 23:809-810. [PMID: 28067971 DOI: 10.1111/odi.12636] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
32
|
Yang SL, Zhu GX, Yin SC, Chen HY, Zhang YQ, Lai W. [Analysis of the results of patch test in 192 patients with hand eczema]. ZHONGHUA LAO DONG WEI SHENG ZHI YE BING ZA ZHI = ZHONGHUA LAODONG WEISHENG ZHIYEBING ZAZHI = CHINESE JOURNAL OF INDUSTRIAL HYGIENE AND OCCUPATIONAL DISEASES 2016; 34:770-772. [PMID: 28043252 DOI: 10.3760/cma.j.issn.1001-9391.2016.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Objective: To investigate the common allergens in the patients with hand eczema. Methods: From November 2014 to March 2016, the patients with hand eczema were tested by the patch test kit of daily life series. Results: The results of the patch test of 192 patients with hand eczema were collected. Allergens were detected in 178 (92.71%) cases. The top 5 allergens were nickel chloride (23.96%) , cobalt chloride (18.75%) , aromatic compounds (17.19%) , nickel sulfate (16.67%) and thimerosal (13.54%). The positive rates of kappa mixture, aromatic compounds, tertiary butyl phenolic resin in males were 16.88% , 14.29% , 11.69% , respectively, which were higher than those (5.22% , 4.35% , 3.48%) in females. Conclusion: Nickel chloride, cobalt chloride, aromatic compounds, nickel sulfate and thimerosal are common allergens in patients with hand eczema.
Collapse
|
33
|
Cai L, Gu J, Zheng J, Zheng M, Wang G, Xi LY, Hao F, Liu XM, Sun QN, Wang Y, Lai W, Fang H, Tu YT, Sun Q, Chen J, Gao XH, Gu Y, Teixeira HD, Zhang JZ, Okun MM. Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study. J Eur Acad Dermatol Venereol 2016; 31:89-95. [PMID: 27504914 PMCID: PMC5215651 DOI: 10.1111/jdv.13746] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2016] [Accepted: 03/30/2016] [Indexed: 12/31/2022]
Abstract
Background This phase 3 trial is the first to evaluate the efficacy and safety of treatment with the systemic TNF‐α inhibitor, adalimumab, for Chinese patients with moderate‐to‐severe plaque psoriasis. Methods In the 12‐week, double‐blind, placebo‐controlled Period A, patients were randomized 4 : 1 to receive adalimumab 40 mg every‐other‐week (following a single 80 mg dose), or placebo every‐other‐week. In the subsequent 12‐week, open‐label, Period B, all patients received adalimumab 40 mg every‐other‐week starting at week 13, following a single, blinded dose at week 12 of adalimumab 80 mg or matching placebo (for patients receiving placebo or adalimumab in Period A respectively). In Period A, efficacy was analysed for all randomized patients and safety for all patients receiving ≥1 dose of the study drug. Results For the 425 patients in this study (87 placebo; 338 adalimumab), a higher percentage randomized to adalimumab achieved the primary endpoint of ≥75% improvement from baseline in PASI score (PASI 75) at week 12: placebo 11.5% (10/87); adalimumab 77.8% (263/338; P < 0.001). Physician's Global Assessment of clear to minimal was achieved at week 12 by 14.9% placebo (13/87) and 80.5% adalimumab (272/338; P < 0.001). For patients who received adalimumab at any time during the study (All‐adalimumab Population), treatment‐emergent adverse events (AEs) were reported by 63.4%; the most common was upper respiratory infection (16.1%). Serious AEs were reported by 3.5% of the All‐adalimumab Population, and serious infectious AEs by 1.2%, which include lung infection, pneumonia and tuberculosis [2 (0.5%) patients each]. There was one death (chronic heart failure). Conclusion In these Chinese patients with moderate‐to‐severe psoriasis, a significantly greater percentage treated with adalimumab compared with placebo achieved efficacy endpoints at week 12 and efficacy was sustained to week 24. Safety results were consistent with the known adalimumab safety profile; no new safety signals were identified in the 24 weeks of treatment.
Collapse
|
34
|
Huang R, Wang J, Wu D, Long H, Yang X, Liu H, Gao X, Zhao R, Lai W. The effects of customised brainwave music on orofacial pain induced by orthodontic tooth movement. Oral Dis 2016; 22:766-774. [PMID: 27417074 DOI: 10.1111/odi.12542] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Revised: 07/08/2016] [Accepted: 07/08/2016] [Indexed: 02/05/2023]
|
35
|
Huang L, Lai W, Zhu L, Chen CH. OA3-4 LB Elimination of HIV-1 latently infected cells by PKC agonist gnidimacrin alone and in combination with a histone deacetylase inhibitor. J Virus Erad 2016. [DOI: 10.1016/s2055-6640(20)31016-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
36
|
Huang Q, Lai W, Yuan C, Shen S, Cui D, Zhao J, Lin J, Ren H, Yang M. Predictors of intestinal pseudo-obstruction in systemic lupus erythematosus complicated by digestive manifestations: data from a Southern China lupus cohort. Lupus 2015; 25:248-54. [PMID: 26405024 DOI: 10.1177/0961203315605366] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2015] [Accepted: 08/12/2015] [Indexed: 01/07/2023]
Abstract
Objective To determine factors that may predict intestinal pseudo-obstruction (IpsO) in systemic lupus erythematosus (SLE) patients complicated by digestive manifestations. Methods SLE patients with digestive manifestations ( n = 135) were followed at Southern Medical University affiliated Nanfang Hospital from 2000 until 2013. Demographic variables, clinical features, and laboratory data were compared between the two groups. Univariate and multivariate logistic regression models were used to establish factors that predispose to IpsO in these patients. Results At the end of the study period, 32 (23.7%) patients had developed IpsO. Mortality (9 patients) was infrequent and the cause of death was unrelated to IpsO. Independent predictors of IpsO in SLE were ureterectasia, anti-U1 RNP+, peritonitis, and low C3 levels. Conclusions Regular abdominal X-ray examinations are recommended in SLE patients with ureterectasia, anti-U1 RNP+, peritonitis, or low C3 levels, as early diagnosis and therapy may prevent unnecessary surgical intervention and improve the disease course.
Collapse
|
37
|
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Bennett DW, Bennett JV, Bertani M, Bettoni D, Bian JM, Bianchi F, Boger E, Bondarenko O, Boyko I, Briere RA, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen HY, Chen JC, Chen ML, Chen SJ, Chen X, Chen XR, Chen YB, Cheng HP, Chu XK, Cibinetto G, Cronin-Hennessy D, Dai HL, Dai JP, Dbeyssi A, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Duan PF, Fan JZ, Fang J, Fang SS, Fang X, Fang Y, Fava L, Feldbauer F, Felici G, Feng CQ, Fioravanti E, Fritsch M, Fu CD, Gao Q, Gao Y, Gao Z, Garzia I, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo Y, Guo YP, Haddadi Z, Hafner A, Han S, Han YL, Hao XQ, Harris FA, He KL, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Hu Y, Huang GM, Huang GS, Huang HP, Huang JS, Huang XT, Huang Y, Hussain T, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang LW, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Johansson T, Julin A, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Kliemt R, Kloss B, Kolcu OB, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange JS, Lara M, Larin P, Leng C, Li CH, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li J, Li K, Li K, Li L, Li PR, Li T, Li WD, Li WG, Li XL, Li XM, Li XN, Li XQ, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Lin DX, Liu BJ, Liu CX, Liu FH, Liu F, Liu F, Liu HB, Liu HH, Liu HH, Liu HM, Liu J, Liu JP, Liu JY, Liu K, Liu KY, Liu LD, Liu PL, Liu Q, Liu SB, Liu X, Liu XX, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu HJ, Lu JG, Lu RQ, Lu Y, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Lyu XR, Ma FC, Ma HL, Ma LL, Ma QM, Ma S, Ma T, Ma XN, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Marcello S, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Mo YJ, Morales Morales C, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu SL, Niu XY, Olsen SL, Ouyang Q, Pacetti S, Patteri P, Pelizaeus M, Peng HP, Peters K, Pettersson J, Ping JL, Ping RG, Poling R, Pu YN, Qi M, Qian S, Qiao CF, Qin LQ, Qin N, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Redmer CF, Ren HL, Ripka M, Rong G, Ruan XD, Santoro V, Sarantsev A, Savrié M, Schoenning K, Schumann S, Shan W, Shao M, Shen CP, Shen PX, Shen XY, Sheng HY, Song WM, Song XY, Sosio S, Spataro S, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Tiemens M, Toth D, Ullrich M, Uman I, Varner GS, Wang B, Wang BL, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang W, Wang XF, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZH, Wang ZY, Weber T, Wei DH, Wei JB, Weidenkaff P, Wen SP, Wiedner U, Wolke M, Wu LH, Wu Z, Xia LG, Xia Y, Xiao D, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu L, Xu QJ, Xu QN, Xu XP, Yan L, Yan WB, Yan WC, Yan YH, Yang HX, Yang L, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yin JH, Yu BX, Yu CX, Yu HW, Yu JS, Yuan CZ, Yuan WL, Yuan Y, Yuncu A, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang K, Zhang L, Zhang SH, Zhang XY, Zhang Y, Zhang YH, Zhang YT, Zhang ZH, Zhang ZP, Zhang ZY, Zhao G, Zhao JW, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao QW, Zhao SJ, Zhao TC, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhou L, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhu K, Zhu KJ, Zhu S, Zhu XL, Zhu YC, Zhu YS, Zhu ZA, Zhuang J, Zotti L, Zou BS, Zou JH. Observation of the ψ(1 3D2) State in e+e-→π+π-γχc1 at BESIII. PHYSICAL REVIEW LETTERS 2015; 115:011803. [PMID: 26182091 DOI: 10.1103/physrevlett.115.011803] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/26/2015] [Indexed: 06/04/2023]
Abstract
We report the observation of the X(3823) state in the process e+e-→π+π-X(3823)→π+π-γχc1 with a statistical significance of 6.2σ, in data samples at center-of-mass energies sqrt[s]=4.230, 4.260, 4.360, 4.420, and 4.600 GeV collected with the BESIII detector at the BEPCII electron positron collider. The measured mass of the X(3823) state is (3821.7±1.3±0.7) MeV/c2, where the first error is statistical and the second systematic, and the width is less than 16 MeV at the 90% confidence level. The products of the Born cross sections for e+e-→π+π-X(3823) and the branching ratio B[X(3823)→γχc1,c2] are also measured. These measurements are in good agreement with the assignment of the X(3823) state as the ψ(1 3D2) charmonium state.
Collapse
|
38
|
Jin B, Zhou X, Li B, Lai W, Li X. Influence of In vitro Digestion on Antioxidative Activity of Coconut Meat Protein Hydrolysates. TROP J PHARM RES 2015. [DOI: 10.4314/tjpr.v14i3.12] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
39
|
Jiang Y, Yan B, Lai W, Shi Y, Xiao D, Jia J, Liu S, Li H, Lu J, Li Z, Chen L, Chen X, Sun L, Muegge K, Cao Y, Tao Y. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8. Oncogene 2015; 34:6079-91. [PMID: 25745994 PMCID: PMC4564361 DOI: 10.1038/onc.2015.53] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2014] [Revised: 12/11/2014] [Accepted: 12/16/2014] [Indexed: 12/26/2022]
Abstract
Epstein-Barr virus (EBV) causes human lymphoid malignancies, and the EBV product latent membrane protein 1 (LMP1) has been identified as an oncogene in epithelial carcinomas such as nasopharyngeal carcinoma (NPC). EBV can epigenetically reprogram lymphocyte specific processes and induce cell immortalization. However, the interplay between LMP1 and the NPC host cell remains largely unknown. Here, we report that LMP1 is important to establish the Hox gene expression signature in NPC cell lines and tumor biopsies. LMP1 induces repression of several Hox genes in part via stalling of RNA Pol II. Pol II stalling can be overcome by irradiation involving the epigenetic regulator TET3. Furthermore, we report that HoxC8, one of the genes silenced by LMP1, plays a role in tumor growth. Ectopic expression of HoxC8 inhibits NPC cell growth in vitro and in vivo, modulates glycolysis and regulates the expression of TCA-cycle related genes. We propose that viral latency products may repress via stalling key mediators that in turn modulate glycolysis.
Collapse
|
40
|
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Ferroli RB, Ban Y, Bennett DW, Bennett JV, Bertani M, Bettoni D, Bian JM, Bianchi F, Boger E, Bondarenko O, Boyko I, Briere RA, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen HY, Chen JC, Chen ML, Chen SJ, Chen X, Chen XR, Chen YB, Cheng HP, Chu XK, Chu YP, Cibinetto G, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Duan PF, Fan JZ, Fang J, Fang SS, Fang X, Fang Y, Fava L, Feldbauer F, Felici G, Feng CQ, Fioravanti E, Fu CD, Gao Q, Gao Y, Garzia I, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo Y, Guo YP, Haddadi Z, Hafner A, Han S, Han YL, Harris FA, He KL, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Hu Y, Huang GM, Huang GS, Huang HP, Huang JS, Huang XT, Huang Y, Hussain T, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang LW, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Johansson T, Julin A, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Kliemt R, Kloss B, Kolcu OB, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange JS, Lara M, Larin P, Li C, Li CH, Li DM, Li F, Li G, Li HB, Li JC, Li J, Li K, Li K, Li PR, Li T, Li WD, Li WG, Li XL, Li XM, Li XN, Li XQ, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Lin DX, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu HB, Liu HH, Liu HH, Liu HM, Liu J, Liu JP, Liu JY, Liu K, Liu KY, Liu LD, Liu Q, Liu SB, Liu X, Liu XX, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu HJ, Lu JG, Lu RQ, Lu Y, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Lyu XR, Ma FC, Ma HL, Ma LL, Ma QM, Ma S, Ma T, Ma XN, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Marcello S, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Mo YJ, Moeini H, Morales CM, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu SL, Niu XY, Olsen SL, Ouyang Q, Pacetti S, Patteri P, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Pu YN, Qi M, Qian S, Qiao CF, Qin LQ, Qin N, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Redmer CF, Ren HL, Ripka M, Rong G, Ruan XD, Santoro V, Sarantsev A, Savrié M, Schoenning K, Schumann S, Shan W, Shao M, Shen CP, Shen PX, Shen XY, Sheng HY, Shepherd MR, Song WM, Song XY, Sosio S, Spataro S, Spruck B, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Tiemens M, Toth D, Ullrich M, Uman I, Varner GS, Wang B, Wang BL, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang W, Wang XF, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZH, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen SP, Wiedner U, Wolke M, Wu LH, Wu Z, Xia LG, Xia Y, Xiao D, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu L, Xu QJ, Xu QN, Xu XP, Yan L, Yan WB, Yan WC, Yan YH, Yang HX, Yang L, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yin JH, Yu BX, Yu CX, Yu HW, Yu JS, Yuan CZ, Yuan WL, Yuan Y, Yuncu A, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang K, Zhang L, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZH, Zhang ZP, Zhang ZY, Zhao G, Zhao JW, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao QW, Zhao SJ, Zhao TC, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhou L, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhu K, Zhu KJ, Zhu S, Zhu XL, Zhu YC, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Study of e(+)e(-)→ωχ(cJ) at center of mass energies from 4.21 to 4.42 GeV. PHYSICAL REVIEW LETTERS 2015; 114:092003. [PMID: 25793804 DOI: 10.1103/physrevlett.114.092003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/27/2014] [Indexed: 06/04/2023]
Abstract
Based on data samples collected with the BESIII detector at the BEPCII collider at nine center of mass energies from 4.21 to 4.42 GeV, we search for the production of e^{+}e^{-}→ωχ_{cJ} (J=0, 1, 2). The process e^{+}e^{-}→ωχ_{c0} is observed for the first time, and the Born cross sections at sqrt[s]=4.23 and 4.26 GeV are measured to be (55.4±6.0±5.9) and (23.7±5.3±3.5) pb, respectively, where the first uncertainties are statistical and the second are systematic. The ωχ_{c0} signals at the other seven energies and the e^{+}e^{-}→ωχ_{c1} and ωχ_{c2} signals are not significant, and the upper limits on the cross sections are determined. By examining the ωχ_{c0} cross section as a function of center of mass energy, we find that it is inconsistent with the line shape of the Y(4260) observed in e^{+}e^{-}→π^{+}π^{-}J/ψ. Assuming the ωχ_{c0} signals come from a single resonance, we extract the mass and width of the resonance to be (4230±8±6) MeV/c^{2} and (38±12±2) MeV, respectively, and the statistical significance is more than 9σ.
Collapse
|
41
|
Ablikim M, Achasov M, Ai X, Albayrak O, Albrecht M, Ambrose D, Amoroso A, An F, An Q, Bai J, Baldini Ferroli R, Ban Y, Bennett D, Bennett J, Bertani M, Bettoni D, Bian J, Bianchi F, Boger E, Bondarenko O, Boyko I, Briere R, Cai H, Cai X, Cakir O, Calcaterra A, Cao G, Cetin S, Chang J, Chelkov G, Chen G, Chen H, Chen H, Chen J, Chen M, Chen S, Chen X, Chen X, Chen Y, Cheng H, Chu X, Cibinetto G, Cronin-Hennessy D, Dai H, Dai J, Dbeyssi A, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong L, Dong M, Du S, Duan P, Fan J, Fang J, Fang S, Fang X, Fang Y, Fava L, Feldbauer F, Felici G, Feng C, Fioravanti E, Fritsch M, Fu C, Gao Q, Gao Y, Garzia I, Goetzen K, Gong W, Gradl W, Greco M, Gu M, Gu Y, Guan Y, Guo A, Guo L, Guo T, Guo Y, Guo Y, Haddadi Z, Hafner A, Han S, Han Y, Harris F, He K, He Z, Held T, Heng Y, Hou Z, Hu C, Hu H, Hu J, Hu T, Hu Y, Huang G, Huang G, Huang H, Huang J, Huang X, Huang Y, Hussain T, Ji Q, Ji Q, Ji X, Ji X, Jiang L, Jiang L, Jiang X, Jiao J, Jiao Z, Jin D, Jin S, Johansson T, Julin A, Kalantar-Nayestanaki N, Kang X, Kang X, Kavatsyuk M, Ke B, Kliemt R, Kloss B, Kolcu O, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange J, Lara M, Larin P, Li C, Li C, Li D, Li F, Li G, Li H, Li J, Li J, Li K, Li K, Li P, Li T, Li W, Li W, Li X, Li X, Li X, Li X, Li Z, Liang H, Liang Y, Liang Y, Liao G, Lin D, Liu B, Liu C, Liu C, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu H, Liu J, Liu J, Liu J, Liu K, Liu K, Liu L, Liu P, Liu Q, Liu S, Liu X, Liu X, Liu Y, Liu Z, Liu Z, Liu Z, Loehner H, Lou X, Lu H, Lu J, Lu R, Lu Y, Lu Y, Luo C, Luo M, Luo T, Luo X, Lv M, Lyu X, Ma F, Ma H, Ma L, Ma Q, Ma S, Ma T, Ma X, Ma X, Maas F, Maggiora M, Malik Q, Mao Y, Mao Z, Marcello S, Messchendorp J, Min J, Min T, Mitchell R, Mo X, Mo Y, Morales Morales C, Moriya K, Muchnoi N, Muramatsu H, Nefedov Y, Nerling F, Nikolaev I, Ning Z, Nisar S, Niu S, Niu X, Olsen S, Ouyang Q, Pacetti S, Patteri P, Pelizaeus M, Peng H, Peters K, Ping J, Ping R, Poling R, Pu Y, Qi M, Qian S, Qiao C, Qin L, Qin N, Qin X, Qin Y, Qin Z, Qiu J, Rashid K, Redmer C, Ren H, Ripka M, Rong G, Ruan X, Santoro V, Sarantsev A, Savrié M, Schoenning K, Schumann S, Shan W, Shao M, Shen C, Shen P, Shen X, Sheng H, Shepherd M, Song W, Song X, Sosio S, Spataro S, Spruck B, Sun G, Sun J, Sun S, Sun Y, Sun Y, Sun Z, Sun Z, Tang C, Tang X, Tapan I, Thorndike E, Tiemens M, Toth D, Ullrich M, Uman I, Varner G, Wang B, Wang B, Wang D, Wang D, Wang K, Wang L, Wang L, Wang M, Wang P, Wang P, Wang Q, Wang S, Wang W, Wang X, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Weber T, Wei D, Wei J, Weidenkaff P, Wen S, Wiedner U, Wolke M, Wu L, Wu Z, Xia L, Xia Y, Xiao D, Xiao Z, Xie Y, Xu G, Xu L, Xu Q, Xu Q, Xu X, Yan L, Yan W, Yan W, Yan Y, Yang H, Yang L, Yang Y, Yang Y, Ye H, Ye M, Ye M, Yin J, Yu B, Yu C, Yu H, Yu J, Yuan C, Yuan W, Yuan Y, Yuncu A, Zafar A, Zallo A, Zeng Y, Zhang B, Zhang B, Zhang C, Zhang C, Zhang D, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang K, Zhang L, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao J, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao Q, Zhao S, Zhao T, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng W, Zheng Y, Zhong B, Zhou L, Zhou L, Zhou X, Zhou X, Zhou X, Zhou X, Zhu K, Zhu K, Zhu S, Zhu X, Zhu Y, Zhu Y, Zhu Z, Zhuang J, Zou B, Zou J. Precision measurement of theD*0decay branching fractions. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.031101] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
42
|
Lai W, Yen H, Lin C, Chiang S. The effects of dietary medium-chain triacylglycerols on growth performance and intestinal microflora in young pigs. JOURNAL OF ANIMAL AND FEED SCIENCES 2014. [DOI: 10.22358/jafs/65669/2014] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Li RY, Wang AP, Xu JH, Xi LY, Fu MH, Zhu M, Xu ML, Li XQ, Lai W, Liu WD, Lu XY, Gong ZQ. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study. Clin Drug Investig 2014; 34:223-30. [PMID: 24477462 PMCID: PMC3926983 DOI: 10.1007/s40261-014-0171-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Background and objectives Superficial fungal skin infections are treated using topical antifungals. The aim of this study was to demonstrate the efficacy of a single application of 1 % terbinafine film-forming solution (FFS) versus placebo for the treatment of tinea pedis in the Chinese population. Methods Six centers in China randomized 290 patients in a 1:1 ratio to receive either 1 % terbinafine FFS or FFS vehicle (placebo) once on the affected foot/feet. Efficacy assessments included microscopy and mycologic culture, and assessing clinical signs and symptoms at baseline, and at weeks 1 and 6 after the topical treatment. All adverse events were recorded. Results At week 6, 1 % terbinafine FFS was superior to placebo for effective treatment rate (63 vs. 8 %); clinical cure (30 vs. 6 %); mycological cure (86 vs. 12 %); negative microscopy (90 vs. 24 %); and negative mycological culture (90 vs. 27 %): all p ≤ 0.001 and clinically relevant. At week 6, 1 % terbinafine FFS was clinically superior to placebo for the absence of: erythema (69 vs. 29 %); desquamation (33 vs. 8 %); and pruritus (70 vs. 30 %): all p ≤ 0.001 and clinically relevant. At week 6, differences in the average total signs and symptoms scores were significantly lower for 1 % terbinafine FFS versus placebo (p ≤ 0.001). Both 1 % terbinafine FFS and placebo were safe and well tolerated based on adverse events and investigator and patient assessments. Conclusions This double-blind, randomized, multicenter study demonstrated one single topical application of 1 % terbinafine FFS was safe and effective in the treatment of tinea pedis in the Chinese population.
Collapse
|
44
|
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Bennett DW, Bennett JV, Bertani M, Bettoni D, Bian JM, Bianchi F, Boger E, Bondarenko O, Boyko I, Briere RA, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen HY, Chen JC, Chen ML, Chen SJ, Chen X, Chen XR, Chen YB, Cheng HP, Chu XK, Chu YP, Cibinetto G, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Duan PF, Fan JZ, Fang J, Fang SS, Fang X, Fang Y, Fava L, Feldbauer F, Felici G, Feng CQ, Fioravanti E, Fu CD, Gao Q, Gao Y, Garzia I, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo Y, Guo YP, Haddadi Z, Hafner A, Han S, Han YL, Harris FA, He KL, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Hu Y, Huang GM, Huang GS, Huang HP, Huang JS, Huang XT, Huang Y, Hussain T, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang LW, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Johansson T, Julin A, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Kliemt R, Kloss B, Kolcu OB, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange JS, Lara M, Larin P, Leyhe M, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li J, Li K, Li K, Li QJ, Li T, Li WD, Li WG, Li XL, Li XM, Li XN, Li XQ, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Lin DX, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu HB, Liu HH, Liu HH, Liu HM, Liu J, Liu JP, Liu JY, Liu K, Liu KY, Liu LD, Liu Q, Liu SB, Liu X, Liu XX, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu HJ, Lu JG, Lu RQ, Lu Y, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Lyu XR, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XN, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Marcello S, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Mo YJ, Moeini H, Morales Morales C, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu SL, Niu XY, Olsen SL, Ouyang Q, Pacetti S, Patteri P, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Pu YN, Qi M, Qian S, Qiao CF, Qin LQ, Qin N, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Redmer CF, Ren HL, Ripka M, Rong G, Ruan XD, Santoro V, Sarantsev A, Savrié M, Schoenning K, Schumann S, Shan W, Shao M, Shen CP, Shen PX, Shen XY, Sheng HY, Shepherd MR, Song WM, Song XY, Sosio S, Spataro S, Spruck B, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Tiemens M, Toth D, Ullrich M, Uman I, Varner GS, Wang B, Wang BL, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang W, Wang XF, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZH, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen SP, Wiedner U, Wolke M, Wu LH, Wu Z, Xia LG, Xia Y, Xiao D, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu L, Xu QJ, Xu QN, Xu XP, Xue Z, Yan L, Yan WB, Yan WC, Yan YH, Yang HX, Yang L, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yin JH, Yu BX, Yu CX, Yu HW, Yu JS, Yuan CZ, Yuan WL, Yuan Y, Yuncu A, Zafar AA, Zallo A, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HT, Zhang HY, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang K, Zhang L, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZH, Zhang ZP, Zhang ZY, Zhao G, Zhao JW, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao QW, Zhao SJ, Zhao TC, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zhong B, Zhou L, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhu K, Zhu KJ, Zhu S, Zhu XL, Zhu YC, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Observation of e(+)e(-)→π(0)π(0)hc and a neutral charmoniumlike structure Zc(4020)(0). PHYSICAL REVIEW LETTERS 2014; 113:212002. [PMID: 25479489 DOI: 10.1103/physrevlett.113.212002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2014] [Indexed: 06/04/2023]
Abstract
Using data collected with the BESIII detector operating at the Beijing Electron Positron Collider at center-of-mass energies of sqrt[s]=4.23, 4.26, and 4.36 GeV, we observe e(+)e(-)→π(0)π(0)hc for the first time. The Born cross sections are measured and found to be about half of those of e(+)e(-)→π(+)π(-)hc within less than 2σ. In the π(0)hc mass spectrum, a structure at 4.02 GeV/c(2) is found. It is most likely to be the neutral isospin partner of the Zc(4020)(±) observed in the process of e(+)e(-)→π(+)π(-)hc being found. A fit to the π(0)hc invariant mass spectrum, with the width of the Zc(4020)(0) fixed to that of its charged isospin partner and possible interferences with non-Zc(4020)(0) amplitudes neglected, gives a mass of (4023.9±2.2±3.8) MeV/c(2) for the Zc(4020)(0), where the first error is statistical and the second systematic.
Collapse
|
45
|
Lai W, Zheng X, Huang Q, Wu X, Yang M. Down-regulating ATDC inhibits the proliferation of esophageal carcinoma cells. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2014; 18:3511-3516. [PMID: 25491629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Our previous study showed that Ataxia-Telangiectasia Group D Complementing gene (ATDC) expression was correlated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma (ESCC). However, the roles of ATDC on the esophageal carcinoma cells remain unclear. The present study aimed to explore the effects of ATDC gene silencing on the growth and proliferation of esophageal carcinoma cell lines EC109 and EC9706 in vivo and in vitro. MATERIALS AND METHODS The lentivirus-mediated siRNA targeting ATDC was constructed and transfected into EC109 and EC9706 cells. After the gene silencing effects were confirmed by Western blot analyses, the growth and proliferation were determined by MTT, palte clone and flow cytometry analyses. RESULTS The lentivirus-mediated siRNA markedly inhibited the expression of ATDC in both EC109 and EC9706 cells. MTT, plate colony formation and Xenograft assays illustrated that down-regulation of ATDC significantly repressed the growth of cells in vitro and in vivo. Furthermore, western blot assays revealed that ATDC down-regulation could decrease the expression of cyclinE in ESCC cell lines. CONCLUSIONS We demonstrated that down-regulation of ATDC could inhibit the growth and proliferation partly through regulation of cyclin E.
Collapse
|
46
|
Zhang YQ, Guan L, Zhong ZY, Chang M, Zhang DK, Li H, Lai W. The anti-inflammatory effect of cherry blossom extract (Prunus yedoensis) used in soothing skincare product. Int J Cosmet Sci 2014; 36:527-30. [PMID: 25065693 DOI: 10.1111/ics.12149] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2014] [Accepted: 06/15/2014] [Indexed: 12/30/2022]
Abstract
OBJECTIVE Previous investigations suggested that cherry blossoms could provide valuable bioactive materials. However, few observations regarding the anti-inflammatory effect of cherry blossoms were reported. This study was to explore the anti-inflammatory effect of cherry blossom extract (CBE), which was used as a soothing ingredient in skincare product. METHODS In vitro study, the anti-inflammatory effect of CBE on the nitric oxide (NO) inhibition assay in lipopolysaccharide (LPS)-treated RAW 264.7 cells was investigated. In vivo study, 40 volunteers were included in a randomized, single-blinded, placebo-controlled trial. 24-hour-occlusive test chambers were applied on the flexor side of the forearm with 3% sodium lauryl sulphate (SLS). Subsequently, the test areas were treated on 9 subsequent days with a cream containing 3% CBE or a placebo. Evaluation included a visual score and determination of erythema value (E value). RESULTS In vitro study, 2% CBE reduced NO production by 31.83% compared to the placebo. In the SLS irritant patch test, the visual score and erythema value of CBE were lower than that of the placebo on D5 and D9. CONCLUSION Cherry blossom extract shows good anti-inflammatory effect in vitro and in vivo and represents a promising functional ingredient in soothing skincare product by reducing skin inflammation.
Collapse
|
47
|
Woolley J, Chuang B, Lam O, Lai W, O’Donovan A, Rankin K, Mathalon D, Vinogradov S. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology 2014; 47:116-25. [PMID: 25001961 PMCID: PMC4280262 DOI: 10.1016/j.psyneuen.2014.04.024] [Citation(s) in RCA: 89] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2013] [Revised: 04/24/2014] [Accepted: 04/30/2014] [Indexed: 01/28/2023]
Abstract
BACKGROUND Individuals with schizophrenia have functionally significant deficits in automatic and controlled social cognition, but no currently available pharmacologic treatments reduce these deficits. The neuropeptide oxytocin has multiple prosocial effects when administered intranasally in humans and there is growing interest in its therapeutic potential in schizophrenia. METHODS We administered 40 IU of oxytocin and saline placebo intranasally to 29 male subjects with schizophrenia and 31 age-matched, healthy controls in a randomized, double-blind, placebo-controlled, cross-over study. Social cognition was assessed with The Awareness of Social Inference Test (TASIT) and the Reading the Mind in the Eyes Test (RMET). We examined the effects of oxytocin administration on automatic social cognition (the ability to rapidly interpret and understand emotional cues from the voice, face, and body); controlled social cognition (the ability to comprehend indirectly expressed emotions, thoughts, and intentions through complex deliberations over longer time periods); and a control task (the ability to comprehend truthful dialog and perform general task procedures) in individuals with and without schizophrenia using mixed factorial analysis of variance models. RESULTS Patients with schizophrenia showed significant impairments in automatic and controlled social cognition compared to healthy controls, and administration of oxytocin significantly improved their controlled, but not automatic, social cognition, F(1, 58)=8.75; p=0.004. Conversely, oxytocin administration had limited effects on social cognition in healthy participants. Patients and controls performed equally well and there were no effects of oxytocin administration on the control task. DISCUSSION Intact social cognitive abilities are associated with better functional outcomes in individuals with schizophrenia. Our data highlight the potentially complex effects of oxytocin on some but not all aspects of social cognition, and support the exploration of intranasal oxytocin as a potential adjunct treatment to improve controlled social cognition in schizophrenia.
Collapse
|
48
|
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Bennett JV, Bertani M, Bian JM, Boger E, Bondarenko O, Boyko I, Braun S, Briere RA, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen X, Chen XR, Chen YB, Cheng HP, Chu XK, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, Ding WM, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Fan JZ, Fang J, Fang SS, Fang Y, Fava L, Feng CQ, Fu CD, Fuks O, Gao Q, Gao Y, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo YP, Han YL, Harris FA, He KL, He M, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Huang GM, Huang GS, Huang HP, Huang JS, Huang L, Huang XT, Huang Y, Hussain T, Ji CS, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang LW, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Johansson T, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Kloss B, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange JS, Lara M, Larin P, Leyhe M, Li CH, Li C, Li C, Li D, Li DM, Li F, Li G, Li HB, Li HJ, Li JC, Li K, Li K, Li L, Li PR, Li QJ, Li T, Li WD, Li WG, Li XL, Li XN, Li XQ, Li ZB, Liang H, Liang YF, Liang YT, Lin DX, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu HB, Liu HH, Liu HM, Liu J, Liu JP, Liu K, Liu KY, Liu PL, Liu Q, Liu SB, Liu X, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu GR, Lu HJ, Lu HL, Lu JG, Lu XR, Lu Y, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Mo YJ, Moeini H, Morales Morales C, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nikolaev IB, Ning Z, Nisar S, Niu XY, Olsen SL, Ouyang Q, Pacetti S, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Q N, Qi M, Qian S, Qiao CF, Qin LQ, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Redmer CF, Ripka M, Rong G, Ruan XD, Sarantsev A, Schoenning K, Schumann S, Shan W, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song WM, Song XY, Spataro S, Spruck B, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Toth D, Ullrich M, Uman I, Varner GS, Wang B, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang W, Wang XF, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZH, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen SP, Werner M, Wiedner U, Wolke M, Wu LH, Wu N, Wu Z, Xia LG, Xia Y, Xiao D, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu L, Xu QJ, Xu QN, Xu XP, Xue Z, Yan L, Yan WB, Yan WC, Yan YH, Yang HX, Yang L, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu HW, Yu JS, Yu SP, Yuan CZ, Yuan WL, Yuan Y, Zafar AA, Zallo A, Zang SL, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CB, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang JJ, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZH, Zhang ZP, Zhang ZY, Zhao G, Zhao JW, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao QW, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zhong B, Zhou L, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhu K, Zhu KJ, Zhu XL, Zhu YC, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Observation of η'→π+ π π+ π- and η'→π+π- π0 π0. PHYSICAL REVIEW LETTERS 2014; 112:251801. [PMID: 25014804 DOI: 10.1103/physrevlett.112.251801] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Indexed: 06/03/2023]
Abstract
Using a sample of 1.3 × 10(9) J/ψ events collected with the BESIII detector, we report the first observation of η(')→π(+)π(-)π(+)π(-) and η(')→π(+)π(-)π(0)π(0). The measured branching fractions are B(η(')→π(+)π(-)π(+)π(-)) = [8.53 ± 0.69(stat.) ± 0.64(syst.)]×10(-5) and B(η(')→π(+)π(-)π(0) π(0)) = [1.82 ± 0.35(stat.) ± 0.18(syst.)] × 10(-4), which are consistent with theoretical predictions based on a combination of chiral perturbation theory and vector-meson dominance.
Collapse
|
49
|
Ablikim M, Achasov M, Ai X, Albayrak O, Albrecht M, Ambrose D, An F, An Q, Bai J, Ferroli RB, Ban Y, Bennett J, Bertani M, Bian J, Boger E, Bondarenko O, Boyko I, Braun S, Briere R, Cai H, Cai X, Cakir O, Calcaterra A, Cao G, Cetin S, Chang J, Chelkov G, Chen G, Chen H, Chen J, Chen M, Chen S, Chen X, Chen X, Chen Y, Cheng H, Chu X, Chu Y, Cronin-Hennessy D, Dai H, Dai J, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, Ding W, Ding Y, Dong C, Dong J, Dong L, Dong M, Du S, Fan J, Fang J, Fang S, Fang Y, Fava L, Feng C, Fu C, Fu J, Fuks O, Gao Q, Gao Y, Geng C, Goetzen K, Gong W, Gradl W, Greco M, Gu M, Gu Y, Guan Y, Guo A, Guo L, Guo T, Guo Y, Han Y, Harris F, He K, He M, He Z, Held T, Heng Y, Hou Z, Hu C, Hu H, Hu J, Hu T, Huang G, Huang G, Huang H, Huang J, Huang L, Huang X, Huang Y, Hussain T, Ji C, Ji Q, Ji Q, Ji X, Ji X, Jiang L, Jiang L, Jiang X, Jiao J, Jiao Z, Jin D, Jin S, Johansson T, Kalantar-Nayestanaki N, Kang X, Kang X, Kavatsyuk M, Kloss B, Kopf B, Kornicer M, Kuehn W, Kupsc A, Lai W, Lange J, Lara M, Larin P, Leyhe M, Li C, Li C, Li C, Li D, Li D, Li F, Li G, Li H, Li J, Li K, Li K, Li L, Li P, Li Q, Li T, Li W, Li W, Li X, Li X, Li X, Li Z, Liang H, Liang Y, Liang Y, Lin D, Liu B, Liu C, Liu C, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu J, Liu J, Liu K, Liu K, Liu P, Liu Q, Liu S, Liu X, Liu Y, Liu Z, Liu Z, Liu Z, Loehner H, Lou X, Lu G, Lu H, Lu H, Lu J, Lu X, Lu Y, Lu Y, Luo C, Luo M, Luo T, Luo X, Lv M, Ma F, Ma H, Ma Q, Ma S, Ma T, Ma X, Maas F, Maggiora M, Malik Q, Mao Y, Mao Z, Messchendorp J, Min J, Min T, Mitchell R, Mo X, Mo Y, Moeini H, Morales CM, Moriya K, Muchnoi N, Muramatsu H, Nefedov Y, Nikolaev I, Ning Z, Nisar S, Niu X, Olsen S, Ouyang Q, Pacetti S, Pelizaeus M, Peng H, Peters K, Ping J, Ping R, Poling R, Q. N, Qi M, Qian S, Qiao C, Qin L, Qin X, Qin Y, Qin Z, Qiu J, Rashid K, Redmer C, Ripka M, Rong G, Ruan X, Sarantsev A, Schoenning K, Schumann S, Shan W, Shao M, Shen C, Shen X, Sheng H, Shepherd M, Song W, Song X, Spataro S, Spruck B, Sun G, Sun J, Sun S, Sun Y, Sun Y, Sun Z, Sun Z, Tang C, Tang X, Tapan I, Thorndike E, Toth D, Ullrich M, Uman I, Varner G, Wang B, Wang D, Wang D, Wang K, Wang L, Wang L, Wang M, Wang P, Wang P, Wang Q, Wang S, Wang W, Wang X, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Wei J, Weidenkaff P, Wen S, Werner M, Wiedner U, Wolke M, Wu L, Wu N, Wu Z, Xia L, Xia Y, Xiao D, Xiao Z, Xie Y, Xiu Q, Xu G, Xu L, Xu Q, Xu Q, Xu X, Xue Z, Yan L, Yan W, Yan W, Yan Y, Yang H, Yang L, Yang Y, Yang Y, Ye H, Ye M, Ye M, Yu B, Yu C, Yu H, Yu J, Yu S, Yuan C, Yuan W, Yuan Y, Yuncu A, Zafar A, Zallo A, Zang S, Zeng Y, Zhang B, Zhang B, Zhang C, Zhang C, Zhang C, Zhang D, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao Q, Zhao S, Zhao T, Zhao X, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng Y, Zhong B, Zhou L, Zhou L, Zhou X, Zhou X, Zhou X, Zhou X, Zhu K, Zhu K, Zhu S, Zhu X, Zhu Y, Zhu Y, Zhu Z, Zhuang J, Zou B, Zou J. Observation of electromagnetic Dalitz decaysJ/ψ→Pe+e−. Int J Clin Exp Med 2014. [DOI: 10.1103/physrevd.89.092008] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
50
|
Ablikim M, Achasov MN, Albayrak O, Ambrose DJ, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Becker J, Bennett JV, Bertani M, Bian JM, Boger E, Bondarenko O, Boyko I, Braun S, Briere RA, Bytev V, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen JC, Chen ML, Chen SJ, Chen XR, Chen YB, Cheng HP, Chu YP, Cronin-Hennessy D, Dai HL, Dai JP, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, Ding WM, Ding Y, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Fava L, Feng CQ, Friedel P, Fu CD, Fu JL, Fuks O, Gao Y, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo T, Guo YP, Han YL, Harris FA, He KL, He M, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Huang GM, Huang GS, Huang JS, Huang L, Huang XT, Huang Y, Hussain T, Ji CS, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang XS, Jiao JB, Jiao Z, Jin DP, Jin S, Jing FF, Kalantar-Nayestanaki N, Kavatsyuk M, Kloss B, Kopf B, Kornicer M, Kuehn W, Lai W, Lange JS, Lara M, Larin P, Leyhe M, Li CH, Li C, Li C, Li DM, Li F, Li G, Li HB, Li JC, Li K, Li L, Li PR, Li QJ, Li WD, Li WG, Li XL, Li XN, Li XQ, Li XR, Li ZB, Liang H, Liang YF, Liang YT, Liao GR, Liao XT, Lin DX, Liu BJ, Liu CL, Liu CX, Liu FH, Liu F, Liu F, Liu H, Liu HB, Liu HH, Liu HM, Liu HW, Liu JP, Liu K, Liu KY, Liu LD, Liu PL, Liu Q, Liu SB, Liu X, Liu YB, Liu ZA, Liu Z, Liu Z, Loehner H, Lou XC, Lu GR, Lu HJ, Lu JG, Lu XR, Lu YP, Luo CL, Luo MX, Luo T, Luo XL, Lv M, Ma FC, Ma HL, Ma QM, Ma S, Ma T, Ma XY, Maas FE, Maggiora M, Malik QA, Mao YJ, Mao ZP, Messchendorp JG, Min J, Min TJ, Mitchell RE, Mo XH, Moeini H, Morales Morales C, Moriya K, Muchnoi NY, Muramatsu H, Nefedov Y, Nikolaev IB, Ning Z, Olsen SL, Ouyang Q, Pacetti S, Park JW, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Poling R, Prencipe E, Qi M, Qian S, Qiao CF, Qin LQ, Qin XS, Qin Y, Qin ZH, Qiu JF, Rashid KH, Redmer CF, Rong G, Ruan XD, Sarantsev A, Shao M, Shen CP, Shen XY, Sheng HY, Shepherd MR, Song WM, Song XY, Spataro S, Spruck B, Sun DH, Sun GX, Sun JF, Sun SS, Sun YJ, Sun YZ, Sun ZJ, Sun ZT, Tang CJ, Tang X, Tapan I, Thorndike EH, Toth D, Ullrich M, Uman I, Varner GS, Wang B, Wang D, Wang DY, Wang K, Wang LL, Wang LS, Wang M, Wang P, Wang PL, Wang QJ, Wang SG, Wang XF, Wang XL, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZG, Wang ZY, Wei DH, Wei JB, Weidenkaff P, Wen QG, Wen SP, Werner M, Wiedner U, Wu LH, Wu N, Wu SX, Wu W, Wu Z, Xia LG, Xia YX, Xiao ZJ, Xie YG, Xiu QL, Xu GF, Xu QJ, Xu QN, Xu XP, Xu ZR, Xue Z, Yan L, Yan WB, Yan YH, Yang HX, Yang Y, Yang YX, Ye H, Ye M, Ye MH, Yu BX, Yu CX, Yu HW, Yu JS, Yu SP, Yuan CZ, Yuan Y, Zafar AA, Zallo A, Zang SL, Zeng Y, Zhang BX, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HH, Zhang HY, Zhang L, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang R, Zhang SH, Zhang XJ, Zhang XY, Zhang Y, Zhang YH, Zhang ZH, Zhang ZP, Zhang ZY, Zhao G, Zhao HS, Zhao JW, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao TC, Zhao XH, Zhao YB, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng YH, Zhong B, Zhou L, Zhou X, Zhou XK, Zhou XR, Zhu C, Zhu K, Zhu KJ, Zhu SH, Zhu XL, Zhu YC, Zhu YS, Zhu ZA, Zhuang J, Zou BS, Zou JH. Observation of a charged charmoniumlike structure in e+ e- → (D* D*)± π∓ at √s = 4.26 GeV. PHYSICAL REVIEW LETTERS 2014; 112:132001. [PMID: 24745407 DOI: 10.1103/physrevlett.112.132001] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2013] [Indexed: 06/03/2023]
Abstract
We study the process e+ e- →(D* D*)± π∓ at a center-of-mass energy of 4.26 GeV using a 827 pb(-1) data sample obtained with the BESIII detector at the Beijing Electron Positron Collider. Based on a partial reconstruction technique, the Born cross section is measured to be (137±9±15) pb. We observe a structure near the (D* D*)± threshold in the π∓ recoil mass spectrum, which we denote as the Zc±(4025). The measured mass and width of the structure are (4026.3±2.6±3.7) MeV/c2 and (24.8±5.6±7.7) MeV, respectively. Its production ratio σ(e+ e- → Zc±(4025)π∓ → (D* D*)± π∓)/σ(e+ e- → (D* D*)± π∓) is determined to be 0.65±0.09±0.06. The first uncertainties are statistical and the second are systematic.
Collapse
|